Molecular Genetics of Relapsed Diffuse Large B-Cell Lymphoma: Insight into Mechanisms of Therapy Resistance

SIMPLE SUMMARY: Many patients with the aggressive cancer diffuse large B-cell lymphoma (DLBCL) still respond poorly to treatment and suffer from relapsed or refractory disease. The identification of gene mutations that are responsible for the outgrowth of the relapsed tumor is crucial to understand...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Berendsen, Madeleine R., Stevens, Wendy B. C., van den Brand, Michiel, van Krieken, J. Han, Scheijen, Blanca
Formatua: Online Artikulua Texto
Hizkuntza:English
Argitaratua: MDPI 2020
Gaiak:
Review
Sarrera elektronikoa:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760867/
https://www.ncbi.nlm.nih.gov/pubmed/33260693
http://dx.doi.org/10.3390/cancers12123553

Antzeko izenburuak